9 research outputs found
First amyloid ÎČ1-42 certified reference material for re-calibrating commercial immunoassays
INTRODUCTION: Reference materials based on human cerebrospinal fluid were certified for the mass concentration of amyloid beta (AÎČ)1-42 (AÎČ42 ). They are intended to be used to calibrate diagnostic assays for AÎČ42 . METHODS: The three certified reference materials (CRMs), ERM-DA480/IFCC, ERM-DA481/IFCC and ERM-DA482/IFCC, were prepared at three concentration levels and characterized using isotope dilution mass spectrometry methods. Roche, EUROIMMUN, and Fujirebio used the three CRMs to re-calibrate their immunoassays. RESULTS: The certified AÎČ42 mass concentrations in ERM-DA480/IFCC, ERM-DA481/IFCC, and ERM-DA482/IFCC are 0.45, 0.72, and 1.22 Όg/L, respectively, with expanded uncertainties (k = 2) of 0.07, 0.11, and 0.18 Όg/L, respectively. Before re-calibration, a good correlation (Pearson's r > 0.97), yet large biases, were observed between results from different commercial assays. After re-calibration the between-assay bias was reduced to < 5%. DISCUSSION: The AÎČ42 CRMs can ensure the equivalence of results between methods and across platforms for the measurement of AÎČ42
A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR
Serial quantification of BCRâABL1 mRNA is an important therapeutic indicator in chronic myeloid leukaemia, but there is a
substantial variation in results reported by diff
Occurrence des amibes libres en rĂ©seaux dâeau intĂ©rieurs
Les amibes libres sont des protozoaires (unicellulaires) trĂšs prĂ©sents dans lâenvironnement et notamment dans les milieux hydriques et ont la capacitĂ© Ă sây multiplier sans lâaide dâun hĂŽte. Certaines espĂšces sont directement pathogĂšnes pour lâhomme mais dâautres peuvent Ă©galement ĂȘtre responsables, de façon indirecte, dâinfections en jouant le rĂŽle de rĂ©servoir de bactĂ©ries pathogĂšnes comme Legionella pneumophila. Afin dâĂ©valuer lâoccurrence des amibes libres en eau chaude sanitaire, une campagne dâanalyse a Ă©tĂ© rĂ©alisĂ©e sur 36 rĂ©seaux intĂ©rieurs rĂ©els (eau froide et eau chaude). La campagne dâanalyse sur sites a montrĂ© que les amibes libres thermophiles sont retrouvĂ©es dans 19 % des prĂ©lĂšvements effectuĂ©s et les amibes mĂ©sophiles dans 46 %. Le genre amibien le plus retrouvĂ© est Hartmanella. A priori, ce genre dâamibe nâest pas intrinsĂšquement pathogĂšne pour lâhomme. Sur quelques Ă©chantillons, des amibes du genre Acanthamoeba ont Ă©tĂ© retrouvĂ©es.
Les points les plus frĂ©quemment contaminĂ©s par les amibes libres sont lâeau froide et les points dâusage. Les caractĂ©ristiques des sites ont Ă©tĂ© mis au regard de la contamination par les amibes totales. Aucune corrĂ©lation nâa pu ĂȘtre trouvĂ©e entre la prĂ©sence dâamibes et le type dâĂ©tablissement, le type de production dâeau chaude, la qualitĂ© du bouclage, le type de matĂ©riaux. TrĂšs peu dâamibes sont retrouvĂ©es lorsque la tempĂ©rature de lâeau est supĂ©rieure Ă 60 °C
A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real time quantitative PCR
Serial quantification of BCRâABL1 mRNA is an important therapeutic indicator in chronic myeloid leukaemia, but there is a substantial variation in results reported by different laboratories. To improve comparability, an internationally accepted plasmid certified reference material (CRM) was developed according to ISO Guide 34:2009. Fragments of BCRâABL1 (e14a2 mRNA fusion), BCR and GUSB transcripts were amplified and cloned into pUC18 to yield plasmid pIRMM0099. Six different linearised plasmid solutions were produced with the following copy number concentrations, assigned by digital PCR, and expanded uncertainties: 1.08±0.13 Ă 106, 1.08±0.11 Ă 105, 1.03±0.10 Ă 104, 1.02±0.09 Ă 103, 1.04±0.10 Ă 102 and 10.0±1.5 copies/?l. The certification of the material for the number of specific DNA fragments per plasmid, copy number concentration of the plasmid solutions and the assessment of inter-unit heterogeneity and stability were performed according to ISO Guide 35:2006. Two suitability studies performed by 63 BCRâABL1 testing laboratories demonstrated that this set of 6 plasmid CRMs can help to standardise a number of measured transcripts of e14a2 BCRâABL1 and three control genes (ABL1, BCR and GUSB). The set of six plasmid CRMs is distributed worldwide by the Institute for Reference Materials and Measurements (Belgium) and its authorised distributors (https://ec.europa.eu/jrc/en/reference-materials/catalogue/; CRM code ERM-AD623a-f)
Vitronectin dictates intraglomerular fibrinolysis in immune-mediated glomerulonephritis
During human glomerulonephritis, the severity of injuries correlates with glomerular fibrin deposits, which are tightly regulated by the intraglomerular fibrinolytic system. Here, we evaluated the role of vitronectin (VTN; also known as complement S protein), the principal cofactor of the plasminogen activator inhibitor-1 (PAI-1), in a mouse model of acute glomerulonephritis. We found that in mice subjected to nephrotoxic serum, the absence of VTN resulted in a lower glomerular PAI-1 activity and a higher glomerular fibrinolytic activity. Challenged VTN-/- mice displayed significantly less fibrin deposits, proteinuria, and renal failure than their wild-type counterparts. Notably, this protective effect afforded by VTN deficiency was still observed after a C3 depletion. Finally, the injection of VTN+/+ serum in VTN-/- mice induced the glomerular deposition of VTN, increased PAI-1 deposition, decreased glomerular fibrinolytic activity, and aggravated glomerular injury. As in mice, abundant glomerular VTN deposits were also observed in patients with severe glomerulonephritis. Here, we show that plasma-exchange therapy, admittedly beneficial in this clinical context, induces a significant depletion in circulating VTN, which might modulate PAI-1 activity locally and accelerate the clearance of fibrin deposits in the glomeruli. Collectively, these results demonstrate that VTN exerts a deleterious role independently from complement, by directing PAI-dependent fibrinolysis in the glomerular compartment.-Mesnard, L., Rafat, C., Vandermeersch, S., Hertig, A., Cathelina, D., Xu-Dubois, Y. -C., Jouanneau, C., Castro Keller, A., Ribeil, J. -A., Leite-de-Moraes, M. C., Rondeau, E. Vitronectin dictates intraglomerular fibrinolysis in immune-mediated glomerulonephritis. FASEB J. 25, 3543-3553 (2011). www.fasebj.orgInstitut National de la Sante et de la Recherche Medicale (INSERM)Faculte de Medecine Pierre et Marie CurieAcademie de MedecineEuropean Renal Association-European Dialysis and Transplant Association (ERA-EDTA)Fundação de Amparo Ă Pesquisa do Estado de SĂŁo Paulo (FAPESP)Conselho Nacional de Desenvolvimento CientĂfico e TecnolĂłgico (CNPq)Univ Paris 06, INSERM, UMR S702, Hop Tenon, F-75020 Paris, FranceUniv Paris 06, Hop Tenon, APHP, F-75020 Paris, FranceHop Necker Enfants Malad, CNRS, UMR 8147, Paris, FranceHop Necker Enfants Malad, APHP, Fac Med Rene Descartes, Dept Biotherapie, Paris, FranceUniversidade Federal de SĂŁo Paulo, Div Nephrol, SĂŁo Paulo, BrazilUniversidade Federal de SĂŁo Paulo, Div Nephrol, SĂŁo Paulo, BrazilFAPESP: 2007/07120-0CNPq: 501848/2009-6Web of Scienc
A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR
Serial quantification of BCR-ABL1 mRNA is an important therapeutic indicator in chronic myeloid leukaemia, but there is a substantial variation in results reported by different laboratories. To improve comparability, an internationally accepted plasmid certified reference material (CRM) was developed according to ISO Guide 34:2009. Fragments of BCR-ABL1 (e14a2 mRNA fusion), BCR and GUSB transcripts were amplified and cloned into pUC18 to yield plasmid pIRMM0099. Six different linearised plasmid solutions were produced with the following copy number concentrations, assigned by digital PCR, and expanded uncertainties: 1.08 +/- 0.13 x 10(6), 1.08 +/- 0.11 x 10(5), 1.03 +/- 0.10 x 10(4), 1.02 +/- 0.09 x 10(3), 1.04 +/- 0.10 x 10(2) and 10.0 +/- 1.5 copies/mu l. The certification of the material for the number of specific DNA fragments per plasmid, copy number concentration of the plasmid solutions and the assessment of inter-unit heterogeneity and stability were performed according to ISO Guide 35:2006. Two suitability studies performed by 63 BCR-ABL1 testing laboratories demonstrated that this set of 6 plasmid CRMs can help to standardise a number of measured transcripts of e14a2 BCR-ABL1 and three control genes (ABL1, BCR and GUSB). The set of six plasmid CRMs is distributed worldwide by the Institute for Reference Materials and Measurements (Belgium) and its authorised distributors (https://ec.europa.eu/jrc/en/reference-materials/catalogue/;CRM code ERM-AD623a-f)